Gland Pharma Grants 16,790 Stock Options Under ESOP 2025

Gland Pharma Ltd announced the grant of 16,790 Employee Stock Options (ESOPs) to 3 employees under its Gland Pharma Employee Stock Option Scheme, 2025. The grant, approved by the ESOP Compensation Committee on July 30, 2026, aligns with SEBI regulations. A portion of the options (11,081) are priced at ₹1258.50, representing 50% of the closing price on NSE on the grant date, while the remaining 5,709 options are priced at the face value of ₹1. The options will vest over three years, starting July 30, 2027, with exercise possible within two years from vesting.